Life science investors are once again smitten with medical device startups. But, biotech entrepreneurs and investors should keep things in perspective.
The Biotechnology Industry Organization is pushing hard to force the US government to change the rules on certain grants for biotechs. Not everybody views this as a wise pursuit.
Several UK universities have given exclusive rights to finance their startups to specialist seed investors, but this monopoly may not be the only way to finance early-stage biotech startups.